Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 3
2005 1
2006 4
2007 1
2009 2
2021 1
2022 4
2023 8
2024 6
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors.
Scafetta R, Donato M, Gullotta C, Guarino A, Fiore C, Sisca L, Speziale E, Troiano R, Foderaro S, Ricozzi V, Iuliani M, Simonetti S, Cavaliere S, Cortellini A, Botticelli A, Scagnoli S, Pisegna S, Criscitiello C, Pedersini R, Sposetti C, Tiberi E, D'Auria G, Vergati M, Mazzotta M, Caputo R, Verrazzo A, Rossino MG, Domati F, Piombino C, Di Lisa FS, Filomeno L, Arcuri T, Puce F, Riva F, Palleschi M, Sirico M, Piras M, Stucci LS, De Lisi D, Orsaria P, Ippolito E, Ramella S, Visani L, Bertini N, Bonaparte I, Gori S, Rossi L, Meattini I, Tagliaferri B, Caffo O, Portarena I, Irelli A, Cretella E, Porta C, Bianchini G, Fabbri A, De Giorgi U, Vici P, Toss A, Garrone O, De Laurentiis M, Villa F, Berardi R, Minelli M, Vernieri C, Curigliano G, Vincenzi B, Tonini G, Santini D, Pantano F. Scafetta R, et al. Among authors: bertini n. Breast. 2025 Aug;82:104502. doi: 10.1016/j.breast.2025.104502. Epub 2025 May 15. Breast. 2025. PMID: 40424680 Free PMC article.
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patients.
Francolini G, Porreca A, Facchini G, Santini D, Bruni A, Simoni N, Trovò M, Osti MF, Fornarini G, Sisani M, Di Cataldo V, Detti B, Garlatti P, Bertini N, Serni S, Minervini A, Livi L. Francolini G, et al. Among authors: bertini n. Med Oncol. 2023 Dec 29;41(1):39. doi: 10.1007/s12032-023-02268-3. Med Oncol. 2023. PMID: 38157111 Clinical Trial.
Biology-guided radiotherapy in metastatic prostate cancer: time to push the envelope?
Lancia A, Ingrosso G, Detti B, Festa E, Bonzano E, Linguanti F, Camilli F, Bertini N, La Mattina S, Orsatti C, Francolini G, Abenavoli EM, Livi L, Aristei C, de Jong D, Al Feghali KA, Siva S, Becherini C. Lancia A, et al. Among authors: bertini n. Front Oncol. 2024 Sep 9;14:1455428. doi: 10.3389/fonc.2024.1455428. eCollection 2024. Front Oncol. 2024. PMID: 39314633 Free PMC article. Review.
Choline PET/CT in recurrent prostate cancer.
Detti B, Carnevale MG, Lucidi S, Burchini L, Caini S, Orsatti C, Bertini N, Roghi M, di Cataldo V, Fondelli S, Ingrosso G, Francolini G, Scartoni D, Sardaro A, Pisani A, Scoccianti S, Aristei C, Livi L. Detti B, et al. Among authors: bertini n. Front Oncol. 2023 Mar 21;13:1079808. doi: 10.3389/fonc.2023.1079808. eCollection 2023. Front Oncol. 2023. PMID: 37025599 Free PMC article.
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches.
Conti V, Corbi G, Sabbatino F, De Pascale D, Sellitto C, Stefanelli B, Bertini N, De Simone M, Liguori L, Di Paola I, De Bernardo M, Tesse A, Rosa N, Pagliano P, Filippelli A. Conti V, et al. Among authors: bertini n. J Pers Med. 2023 Feb 15;13(2):334. doi: 10.3390/jpm13020334. J Pers Med. 2023. PMID: 36836568 Free PMC article. Review.
Current diagnostic and therapeutic options in de novo low-volume metastatic hormone-sensitive prostate cancer.
Ingrosso G, Lancia A, Bardoscia L, Becherini C, Bottero M, Bertini N, Cai T, Caini S, Caserta C, Doccioli C, Festa E, Francolini G, Giacomelli I, Paolieri F, Scartoni D, Pisani AR, Bellavita R, Livi L, Aristei C, Detti B. Ingrosso G, et al. Among authors: bertini n. Expert Rev Anticancer Ther. 2025 Jul;25(7):741-754. doi: 10.1080/14737140.2025.2509760. Epub 2025 May 21. Expert Rev Anticancer Ther. 2025. PMID: 40394918 Review.
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review.
Becherini C, Lancia A, Detti B, Lucidi S, Scartoni D, Ingrosso G, Carnevale MG, Roghi M, Bertini N, Orsatti C, Mangoni M, Francolini G, Marani S, Giacomelli I, Loi M, Pergolizzi S, Bonzano E, Aristei C, Livi L. Becherini C, et al. Among authors: bertini n. Strahlenther Onkol. 2023 Dec;199(12):1173-1190. doi: 10.1007/s00066-023-02097-3. Epub 2023 Jun 22. Strahlenther Onkol. 2023. PMID: 37347290 Free PMC article.
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719).
Francolini G, Bertini N, Di Cataldo V, Garlatti P, Aquilano M, Caini S, Bruni A, Ingrosso G, D'angelillo RM, Tagliaferri L, Augugliaro M, Triggiani L, Parisi S, Timon G, Arcidiacono F, Marvaso G, Jereczek-Fossa BA, Lancia A, Franzese C, Alongi F, Simontacchi G, Greto D, Bonomo P, Loi M, Frosini G, Burchini L, Desideri I, Meattini I, Valicenti RK, Livi L. Francolini G, et al. Among authors: bertini n. Prostate Cancer Prostatic Dis. 2025 Feb 19. doi: 10.1038/s41391-025-00950-3. Online ahead of print. Prostate Cancer Prostatic Dis. 2025. PMID: 39972049
36 results